Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Mentor meeting many roads to reach your goal
Life Science

Mentor meeting many roads to reach your goal

Oslo Cancer Cluster
November 18, 2020

The second-year class of the Researcher Programme at Ullern Upper Secondary School has been assigned new mentors for the school year 2020/2021. The first meeting with the mentors was about how the road to becoming a researcher or doctor or other occupation can be diverse and take many different routes.

IMPRESS leads the way for cancer precision medicine
Life Science

IMPRESS leads the way for cancer precision medicine

Oslo Cancer Cluster
October 20, 2020

IMPRESS Norway is a national clinical study starting in 2021 working towards implementing cancer precision medicine in Norway.

Largest biotech agreement ever made in Norway
Life Science

Largest biotech agreement ever made in Norway

Oslo Cancer Cluster
October 13, 2020

Our member Vaccibody signs multi-million-dollar agreement one week before the company is expected on the stock exchange.

The Lancet Gastroenterology and Hepatology publishes InDex Pharmaceuticals’ results of the phase IIb study with cobitolimod
Life Science

The Lancet Gastroenterology and Hepatology publishes InDex Pharmaceuticals’ results of the phase IIb study with cobitolimod

InDex Pharmaceuticals
October 12, 2020

InDex Pharmaceuticals Holding AB (publ) today announced that the results of the CONDUCT study have been published in the high-impact medical journal The Lancet Gastroenterology and Hepatology.

Experienced Project Leader to Helm Blue Industry Park
Life Science

Experienced Project Leader to Helm Blue Industry Park

Turku Business Region
October 8, 2020

Tero Lahti adds to Blue Industry Park’s repertoire his long and varied experience consisting of things like Meyer Turku’s 300-million-euro investment project.

The new frontier in cancer innovation
Life Science

The new frontier in cancer innovation

Oslo Cancer Cluster
October 7, 2020

Oslo Cancer Cluster (OCC) Innovation Park and Incubator plans to expand by 5o ooo m² in the coming years. The goal is to create an international innovation hub in cancer. Why? Because personalized medicine is changing cancer innovation.

Date
Title
Author
October 6, 2020
MVA-member, BioInnovation Institute, awards EUR 14M to eight innovative and promising start-ups and research projects
Medicon Valley Alliance
October 5, 2020
Clinical studies – important for Norwegian companies
Oslo Cancer Cluster
September 15, 2020
Accelerating cancer research with data sharing
Oslo Cancer Cluster
September 10, 2020
Leveraging Expedited Regulatory Pathways to Optimize Drug Development
NDA
September 10, 2020
The Perceptive Power of Plants in Microbial Selection
MAX IV
September 7, 2020
Apply for Global Bio-based Business Plan Competition
Turku Business Region
September 7, 2020
Medicon Valley Alliance member, Chr. Hansen, will continue to pioneer microbial science to improve food and health, for a more sustainable future as part of new 2025 strategy
Medicon Valley Alliance
September 7, 2020
MVA Annual meeting 2020
Medicon Valley Alliance
September 2, 2020
Market access for immune-oncology products in the EU
NDA
September 1, 2020
DRIVE application open- Fall 2020
Karolinska Institutet Innovations AB
August 28, 2020
Optimising the path to market for ATMPs
NDA
August 28, 2020
Prostatype Genomics AB aims for listing on Nasdaq First North Growth Market - Sedermera Fondkommission is financial advisor
Prostatype Genomics AB
August 28, 2020
Medicon Valley Alliance member Chr. Hansen, will continue to pioneer Microbial science to improve food and health, for a more sustainable future as part of the new 2025 strategy.
Medicon Valley Alliance
August 27, 2020
Ministers meet at Oslo Cancer Cluster
Oslo Cancer Cluster
August 25, 2020
Apply for Novo Nordisk foundation project grants in Bioscience and Basic Biomedicine- Deadline 2nd of September
Medicon Valley Alliance
August 25, 2020
Lytix Biopharma signs licensing agreement
Oslo Cancer Cluster
August 25, 2020
Spago Nanomedical appoints candidate drug in the Tumorad® project
Spago Nanomedical
August 21, 2020
SINTEF in Oslo Science City
Sintef
August 18, 2020
A digital bootcamp for better cancer care
Oslo Cancer Cluster
August 18, 2020
KI Innovations Board of directors – a short presentation
Karolinska Institutet Innovations AB
August 17, 2020
MVA is looking for a project manager - are you their new colleague?
Medicon Valley Alliance
August 13, 2020
Studying medtech with cancer patients at heart
Oslo Cancer Cluster
August 13, 2020
Lift-off for Northbound Startups in Turku
Turku Business Region
August 12, 2020
Webinar Invitation: Biomarker Commercialization - Introduction to European IVD Regulation
Turku Business Region
August 11, 2020
Cobra Biologics Reveals New Brand Identity
Cobra Biologics
August 4, 2020
What’s happened with LightningChart® lately?
Arction Ltd
July 10, 2020
A brief look into ‘performance’ in Web Data Visualization
Arction Ltd
July 7, 2020
LightningChart .NET version 9.1.1 release
Arction Ltd
July 7, 2020
New business column about the Danish life science strategy by MVA chairman of the board Søren Bregenholt & board member and general manager of AbbVie Scandinavia, Linn Mandahl
Medicon Valley Alliance
June 29, 2020
SmiLe Incubator in Lund launches free online program targeting students and early stage entrepeneurs.
Medicon Valley Alliance
June 29, 2020
Nanologica signs agreement with Vicore Pharma worth up to MSEK 8
Nanologica
June 29, 2020
Nanologica engages Per Möller as Scientific Advisor within preparative chromatography
Nanologica
June 25, 2020
Success is no accident- Link Medical
Link Medical
June 24, 2020
Redoxis announces approved Eurostars funding for project E!114520 – ACTION
Redoxis
June 24, 2020
Interview with CEO, Nils Brünner, MVA-member, Scandion Oncology, about the recent partnership with MVA-member, Alligator Bioscience
Medicon Valley Alliance
June 23, 2020
Targovax releases 12-month clinical data
Oslo Cancer Cluster
June 23, 2020
MVA oncology network members partner up and receive a 800,000 EUR grant from Eurostars
Medicon Valley Alliance
June 16, 2020
Grants awarded for PDT/PCI research
Oslo Cancer Cluster
June 16, 2020
Preparing for the Medical Device Regulation
NDA
June 16, 2020
Helping teens in the hospital
Oslo Cancer Cluster
June 12, 2020
Q+A with Mabtech's Head of Research & Development, Bartek Makower- COVID-19 Special.
NLSinsight
June 12, 2020
International Cancer Cluster Showcase 2020
Oslo Cancer Cluster
June 12, 2020
Combating cancer with ultrasound
Oslo Cancer Cluster
June 10, 2020
HiloProbe attracts millions in new investment round
Umeå Biotech Incubator
June 3, 2020
Integrating clinical trials in cancer treatment
Oslo Cancer Cluster
June 3, 2020
Enhancing Pharmacovigilance- To give oncology products the best possible opportunity
NDA
June 3, 2020
DanMAX takes first light
MAX IV
June 2, 2020
High pressure in Swedish drug pipeline
SwedenBIO
June 2, 2020
LightningChart® JS Interactive Examples Update
Arction Ltd
May 29, 2020
Zebrafish PDX models syngergize with mouse PDX models - AACR 2020
BioReperia AB
May 29, 2020
ExPaNDS Project to Link Petabytes of Data Across Europe
MAX IV
May 27, 2020
Xdrop™ at Bioneer – a strategic partnership to tackle challenges in genomics
Bioneer
May 27, 2020
Medicon Valley Alliance, CEO, Petter Hartman, appointed member of Invest in Skåne’s Board of Directors
Medicon Valley Alliance
May 27, 2020
Mentor4Research 2020
Karolinska Institutet Innovations AB
May 26, 2020
InDex Pharmaceuticals presents at Redeye Growth Day 2020
InDex Pharmaceuticals
May 26, 2020
Update from the Biotechgate digital partnering conference
Nanologica
May 25, 2020
Improving proton therapy for cancer patients
Oslo Cancer Cluster
May 25, 2020
Potential Consequences of SARS-CoV-2 to ongoing clinical programs
NDA
May 20, 2020
Cell based 3D immunology assays: mimicking in vivo structures in models of inflammation
Redoxis
May 20, 2020
Getting the body to make its own cancer drugs
Sintef
May 20, 2020
Agrisera acquired by Uppsala life science company Olink
Umeå Biotech Incubator
May 15, 2020
Lipigon signs major new deal with Shanghai-listed HitGen
Umeå Biotech Incubator
May 15, 2020
Tackling SARS CoV-2 viral genome replication machinery using X-rays
MAX IV
May 15, 2020
Medical Device Regulation: Key Changes and what it means for Combination Products
NDA
May 13, 2020
Interview with Managing Director of Merck in Denmark, Enrique Alvarez, about Medicon Valley, healthcare reform and fertility!
Medicon Valley Alliance
May 13, 2020
NLSDays moved to April 20th-21st due to COVID-19. Same location, same opportunities.
NLSinsight
May 13, 2020
Recruitment drive at UmanDiagnostics continues as orders anticipated to rise
Umeå Biotech Incubator
May 12, 2020
COVID-19 patients in intensive care in the Capital Region, Region Zealand, Region Skåne and Region Stockholm
Medicon Valley Alliance
May 12, 2020
Homeschooling for researchers-to-be
Oslo Cancer Cluster
May 12, 2020
Build Skills to Impact goes digital
Karolinska Institutet Innovations AB
May 12, 2020
Interview with Canadian Ambassador to Denmark, Emy Furuya about Life Science, Canada and COVID-19
Medicon Valley Alliance
May 12, 2020
Research on gene-edited embryos allowed
Oslo Cancer Cluster
May 8, 2020
Inspiration from Innovation -Digital
Karolinska Institutet Innovations AB
May 6, 2020
Developing Life Science technologies of Tomorrow - We need your input!
Bioneer
May 6, 2020
Trademark NLAB Saga™ approved in India and Russia
Nanologica
May 5, 2020
New member: Adjutec Pharma
Oslo Cancer Cluster
April 30, 2020
New COVID-19 diagnostics start-up accepted into SmiLe
SmiLe Incubator
April 28, 2020
Artificial intelligence in the fight against COVID-19
Oslo Cancer Cluster
April 24, 2020
Accelerating cell therapies against cancer
Oslo Cancer Cluster
April 24, 2020
Redoxis AB signs a 3-year agreement with Taconic Biosciences, Inc.
Redoxis
April 22, 2020
A Message from Chundsell Medicals AB Regarding COVID-19
Prostatype Genomics AB
April 22, 2020
MVA member, Chr. Hansen, acquires HSO Health Care to grow probiotics offering for women's health
Medicon Valley Alliance
April 22, 2020
New member: Glaxo Smith Kline
Oslo Cancer Cluster
April 22, 2020
Our funding support: up to €60 000 per SME
Oslo Cancer Cluster
April 22, 2020
Q&A with KI Innovations
April 22, 2020
Linn Mandahl, General Manager AbbVie Scandinavia joins the board of directors of the growing DA-SE Life Science cluster organisation, Medicon Valley Alliance
Medicon Valley Alliance
April 22, 2020
Funding opportunities for health and IT SMEs
Oslo Cancer Cluster
April 22, 2020
SmiLe holds introductory business development course
SmiLe Incubator
April 22, 2020
New instrument for varicose vein surgery produces promising results in clinical study
SmiLe Incubator
April 22, 2020
Interview with CEO of Immunitrack, Stephan Thorgrimsen about the fight against the Covid-19 virus
Medicon Valley Alliance
April 22, 2020
Medical Devices and their growing regulatory challenges
NDA
March 12, 2020
New member: Hubro Therapeutics
Oslo Cancer Cluster
March 6, 2020
State visit to Jordan
Oslo Cancer Cluster
March 6, 2020
SmiLe has new laboratory instruments – thanks to Sparbank foundations
SmiLe Incubator
March 6, 2020
Successful companies graduate from SmiLe Incubator
SmiLe Incubator
March 5, 2020
Collaboration across borders- New editorial in 'Life Science Sweden' by MVA CEO, Petter Hartman & Senior strategy & project manager, Sarah Lidé
Medicon Valley Alliance
March 5, 2020
A revolution in vaccine development – but will we all benefit?
Sintef
March 4, 2020
Special Life Science publication distributed with Danish Daily JP (Jyllands-Posten)
Medicon Valley Alliance
March 4, 2020
Nanologica signs distributor agreement for the American, Canadian and European market.
Nanologica
March 3, 2020
AbbVie and Allergan Receive Final European Approval to Close Pending Transaction
AbbVie

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019